Search

Author/Creator Lentz, S. R.

11. Limit of detection and threshold for positivity of the Centers for Disease Control and Prevention assay for factor VIII inhibitors. (14th September 2017)

Authors:
Miller, C. H.; Boylan, B.; Shapiro, A. D.; Lentz, S. R.; Wicklund, B. M.
Other Names:
Abshire T. C. investigator.; Dunn A. L. investigator.; Kempton C. L. investigator.; Soucie J. M. investigator.; Bethea F. investigator.; Payne A. investigator.; Bockenstedt P. L. investigator.; Brettler D. B. investigator.; Di Paola J. A. investigator.; Radhi M. investigator.; Neff A. T. investig...
Journal:
Journal of thrombosis and haemostasis
Issue:
Volume 15:Number 10(2017)
Page Start:
1971
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

12. Long‐term patterns of safety and efficacy of bleeding prophylaxis with turoctocog alfa (NovoEight®) in previously treated patients with severe haemophilia A: interim results of the guardian™2 extension trial. (8th June 2015)

Authors:
Ozelo, M.; Misgav, M.; Abdul Karim, F.; Lentz, S. R.; Martin‐Salces, M.; Matytsina, I.; Saugstrup, T.; Santagostino, E.
Journal:
Haemophilia
Issue:
Volume 21:Number 5(2015:Sep.)
Page Start:
e436
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

13. Recombinant factor VIIa analog in the management of hemophilia with inhibitors: results from a multicenter, randomized, controlled trial of vatreptacog alfa. (16th July 2014)

Authors:
Lentz, S. R.; Ehrenforth, S.; Abdul Karim, F.; Matsushita, T.; Weldingh, K. N.; Windyga, J.; Mahlangu, J. N.; the adept™2 investigators
Journal:
Journal of thrombosis and haemostasis
Issue:
Volume 12:Number 8(2014:Aug.)
Page Start:
1244
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

14. Results from a large multinational clinical trial (guardian™1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacy. (7th May 2013)

Authors:
Lentz, S. R.; Misgav, M.; Ozelo, M.; Šalek, S. Z.; Veljkovic, D.; Recht, M.; Cerqueira, M.; Tiede, A.; Brand, B.; Mancuso, M. E.; Seremetis, S.; Lindblom, A.; Martinowitz, U.
Journal:
Haemophilia
Issue:
Volume 19:Number 5(2013:Sep.)
Page Start:
691
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

15. Safety and efficacy of turoctocog alfa (NovoEight®) during surgery in patients with haemophilia A: results from the multinational guardian™ clinical trials. (2nd October 2014)

Authors:
Santagostino, E.; Lentz, S. R.; Misgav, M.; Brand, B.; Chowdary, P.; Savic, A.; Kilinc, Y.; Amit, Y.; Amendola, A.; Solimeno, L. P.; Saugstrup, T.; Matytsina, I.
Journal:
Haemophilia
Issue:
Volume 21:Number 1(2015:Jan.)
Page Start:
34
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

17. The small‐molecule MERTK inhibitor UNC2025 decreases platelet activation and prevents thrombosis. (12th January 2018)

Authors:
Branchford, B. R.; Stalker, T. J.; Law, L.; Acevedo, G.; Sather, S.; Brzezinski, C.; Wilson, K. M.; Minson, K.; Lee‐Sherick, A. B.; Davizon‐Castillo, P.; Ng, C.; Zhang, W.; Neeves, K. B.; Lentz, S. R.; Wang, X.; Frye, S. V.; Shelton Earp, H.; DeRyckere, D.; Brass, L. F.; Graham, D. K.
Journal:
Journal of thrombosis and haemostasis
Issue:
Volume 16:Number 2(2018)
Page Start:
352
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗